Oncologist Urge FDA to Allow Cancer Patients Access to Silicone Implants, But Continue Study
In Brief: Healy to Name Jay Moskowitz Deputy Direct, Promote Mahoney To Deputy Budge Director
NCI To File Record No. Of INDS In ’92, Expand Phase 1 Trials
Advisors Ok New RFP For Natural Product Large-Scale Production
National Coalition Dinner Honors Cancer Program Founders, Advocates, And Cancer Survivors
DES Exposure Studies Below Payline; NCI Considers Contracts
ICCCR Issues RFP For Cancer Risk Scale
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Johnson and Johnson reaches $5.5B settlement deal over talc lawsuits
- The Directors: New directors Herbst and Gius chart a future built on AI, collaboration, and rural access
- FDA grants Replimune’s RP1 an accelerated approval on third submission after 10:3 vote from advisory committee
Amid political outcry, advisors accept weak data and give sponsor a chance to complete phase III trial - Consumers are increasingly accessing U.S. News rankings of cancer hospitals via AI chatbots
2026 report shows no change in the top-five lineup - What happened at FDA? Replimune approval raises questions









